
(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
This Flashy Old-School Design Trend From Italy Still Has A Place In Modern Kitchens - 2
Live long and loiter: Why NASA's ESCAPADE probes will wait a year in space before heading to Mars - 3
Politics at the table? Drinking the wine you brought? An etiquette expert's Thanksgiving dos and don'ts. - 4
Minute Maid’s frozen juice concentrate is ending after 80 years — and so is a certain kind of kitchen ritual - 5
Dominating Your Cash: The Fundamental Manual for Overseeing Individual accounting records
Artemis II astronauts channel Apollo 8 with a striking Earthset photo
ISS astronaut evacuation shouldn't interfere with upcoming Artemis 2 moon mission, NASA chief says
6 Useful Home Espresso Machines
Manual for Purchasing a Modest Jeep Wrangler for Seniors
Did Japan’s PM Actually Back the Memecoin Bearing Her Name?
Deadly Switzerland ski resort fire was likely started by sparklers attached to champagne bottles, officials say
Arctic is again the hottest it's been in 125 years, with record-low sea ice, NOAA report says
The most effective method to Quick Track Your Outcome in Advanced Showcasing with a Web-based Degree
Vote In favor of Your Favored Web-based Venture Stage












